Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Drayer

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Therapeutic Drug Monitoring|January 1, 1988
Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in manD E Drayer
Clinical Pharmacology and Therapeutics|October 1, 1987
On the use of drugs administered as racematesD E Drayer
Pharmacotherapy|January 1, 1987
Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockersD E Drayer
The American Journal of Medicine|April 1, 1977
Active drug metabolites and renal failureD E Drayer
Annals of the New York Academy of Sciences|January 1, 1984
Clinical consequences of the lipophilicity and plasma protein binding of antiarrhythmic drugs and active metabolites in manD E Drayer
Clinical Pharmacology and Therapeutics|August 1, 1986
Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overviewD E Drayer
Drugs|December 1, 1982
Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerationsD E Drayer
Clinical Pharmacokinetics|November 1, 1976
Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failureD E Drayer
The Medical Clinics of North America|September 1, 1974
Pathways of drug metabolism in manD E Drayer
The Journal of Laboratory and Clinical Medicine|April 1, 1981
Improved method for the measurement of cimetidine in human serum by reverse-phase high-pressure liquid chromatographyB Lorenzo, D E Drayer
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|January 1, 1988
Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in manD E Drayer
Clinical Pharmacology and Therapeutics|October 1, 1987
On the use of drugs administered as racematesD E Drayer
Pharmacotherapy|January 1, 1987
Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockersD E Drayer
The American Journal of Medicine|April 1, 1977
Active drug metabolites and renal failureD E Drayer
Annals of the New York Academy of Sciences|January 1, 1984
Clinical consequences of the lipophilicity and plasma protein binding of antiarrhythmic drugs and active metabolites in manD E Drayer
Clinical Pharmacology and Therapeutics|August 1, 1986
Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overviewD E Drayer
Drugs|December 1, 1982
Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerationsD E Drayer
Clinical Pharmacokinetics|November 1, 1976
Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failureD E Drayer
The Medical Clinics of North America|September 1, 1974
Pathways of drug metabolism in manD E Drayer
The Journal of Laboratory and Clinical Medicine|April 1, 1981
Improved method for the measurement of cimetidine in human serum by reverse-phase high-pressure liquid chromatographyB Lorenzo, D E Drayer
Pageof 7